A Biotech Stock for Income Investors?
In a crashing market, I’d like to read something cheerful. One of things that could lighten up the mood, especially for dividend investors, is an announcement from Amgen, Inc. (NASDAQ:AMGN).
Amgen is a biopharmaceutical.
Amgen Announces Dividend Increase
Today’s chart highlights the power of a growing dividend.
Most income investors want a large, upfront yield. But for those with a little more patience, a smaller, growing distribution can often make a smarter proposition.
Dear Reader: There is no magic formula to getting rich. Success in investment vehicles with the best prospects for price appreciation can only be achieved through proper and rigorous research and analysis. We are 100% independent in that we are not affiliated with any bank or brokerage house. Information contained herein, while believed to be correct, is not guaranteed as accurate. Warning: Investing often involves high risks and you can lose a lot of money. Please do not invest with money you cannot afford to lose. The opinions in this content are just that, opinions of the authors. We are a publishing company and the opinions, comments, stories, reports, advertisements and articles we publish are for informational and educational purposes only; nothing herein should be considered personalized investment advice. Before you make any investment, check with your investment professional (advisor). We urge our readers to review the financial statements and prospectus of any company they are interested in. We are not responsible for any damages or losses arising from the use of any information herein. Past performance is not a guarantee of future results. All registered trademarks are the property of their respective owners
Sign up to receive our FREE Income Investors newsletter along with our special offers and get our FREE report:
5 Dividend Stocks to Own Forever
This is an entirely free service. No credit card required. You can opt-out at anytime.